Jared Freedberg - General Counsel at Intercept Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
ICPT
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jared Freedberg since 9/17/2023

Holdings reported by Jared Freedberg for Intercept Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $19.00 Nov 8, 2023 Direct
Option to Purchase Common Stock 0 Nov 8, 2023 Direct Common Stock

Transactions reported by Jared Freedberg for Intercept Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.